Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cts (CTS) EBIT (2016 - 2025)

Historic EBIT for Cts (CTS) over the last 16 years, with Q3 2025 value amounting to $20.9 million.

  • Cts' EBIT rose 29.7% to $20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $78.0 million, marking a year-over-year increase of 1228.68%. This contributed to the annual value of $71.2 million for FY2024, which is 515.12% down from last year.
  • Cts' EBIT amounted to $20.9 million in Q3 2025, which was up 29.7% from $22.7 million recorded in Q2 2025.
  • Cts' EBIT's 5-year high stood at $26.0 million during Q1 2022, with a 5-year trough of $14.5 million in Q1 2024.
  • For the 5-year period, Cts' EBIT averaged around $19.8 million, with its median value being $19.0 million (2021).
  • Its EBIT has fluctuated over the past 5 years, first skyrocketed by 22968.6% in 2021, then plummeted by 3444.87% in 2024.
  • Cts' EBIT (Quarter) stood at $18.4 million in 2021, then rose by 17.32% to $21.6 million in 2022, then fell by 24.85% to $16.3 million in 2023, then grew by 10.78% to $18.0 million in 2024, then rose by 16.26% to $20.9 million in 2025.
  • Its EBIT stands at $20.9 million for Q3 2025, versus $22.7 million for Q2 2025 and $16.3 million for Q1 2025.